Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

mesothelin

mesothelin is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 19
Pipeline programs 2
News articles 0
Drug details — mesothelin
Class
—
Route
—
Patents
19
Programs
2
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

mesothelin is an FDA-listed pharmaceutical active ingredient.

Key facts

INN mesothelin

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. A Phase 1 Study of JNJ-79032421 Targeting Mes... for Advanced Stage Solid Tumors Phase 1 · Janssen-Cilag International N.V · Advanced Stage Solid Tumors
  2. CT-95 Phase 1 · Context Therapeutics · Mesothelin-Expressing Tumors

Related patents

Browse patents

  1. US 12180296

    Cross species single domain antibodies targeting mesothelin for treating solid tumors

    Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11986517

    Cancer vaccines targeting mesothelin and uses thereof

    Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11932698

    Anti-mesothelin chimeric antigen receptor (CAR) constructs and uses thereof

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11883433

    Chimeric antigen receptor comprising anti-mesothelin scFv, and use thereof

    Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11795215

    Anti-mesothelin chimeric antigen receptor specifically binding to mesothelin

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11390683

    Anti-mesothelin polypeptides and proteins

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11154602

    Cancer vaccines targeting mesothelin and uses thereof

    Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10683362

    Recombinant immunotoxin targeting mesothelin

    Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9803022

    Mesothelin domain-specific monoclonal antibodies and use thereof

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9416190

    Mesothelin antibodies and methods for eliciting potent antitumor activity

    Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9409992

    Mesothelin domain-specific monoclonal antibodies and use thereof

    Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9359447

    Anti-mesothelin chimeric antigen receptors

    Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8623828

    Blocking mesothelin peptide fragments

    Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8460660

    Anti-mesothelin antibodies

    Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8357783

    Human anti-mesothelin monoclonal antibodies

    Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7709252

    Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use

    Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7368110

    Antibodies, including Fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use

    Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7081518

    Anti-mesothelin antibodies having high binding affinity

    Expires Mon Jul 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 6809184

    Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use

    Expires Mon Oct 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is mesothelin?

mesothelin is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.